2010
DOI: 10.1039/b920666n
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of nanoparticles for biomedical applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
26
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(26 citation statements)
references
References 136 publications
0
26
0
Order By: Relevance
“…One of the important aspects of nanotechnology is the possibility to produce some nanostructures via ecological and friendly ways, avoiding the addition of toxic solvents or technologically expensive processes (Mandal et al 2006;Mohanpuria et al 2008;Sinha et al 2009;Durán et al 2010a, b, Narayanan andSakthivel 2010;Arya 2010;Blanco-Andujar et al 2010;Gade et al 2010;Thakkar et al 2010;Popescu et al 2010;Durán et al 2011;Marcato and Durán 2011;Li et al 2011). In this context, the production of metallic oxide nanoparticles via biogenic synthesis is a great new step to the development of chemical materials via new nanobiotechnological pathways.…”
Section: Introductionmentioning
confidence: 97%
“…One of the important aspects of nanotechnology is the possibility to produce some nanostructures via ecological and friendly ways, avoiding the addition of toxic solvents or technologically expensive processes (Mandal et al 2006;Mohanpuria et al 2008;Sinha et al 2009;Durán et al 2010a, b, Narayanan andSakthivel 2010;Arya 2010;Blanco-Andujar et al 2010;Gade et al 2010;Thakkar et al 2010;Popescu et al 2010;Durán et al 2011;Marcato and Durán 2011;Li et al 2011). In this context, the production of metallic oxide nanoparticles via biogenic synthesis is a great new step to the development of chemical materials via new nanobiotechnological pathways.…”
Section: Introductionmentioning
confidence: 97%
“…In addition, MPM can also undergo chemical functionalization, which enables their use as specific ligands for immunoassays, sequencing of nucleic acids, cells, microorganisms and others [40]. In the biomedical field, the polymeric materials presenting bifunctionality are commonly used in applications such as cell separation, drug delivery systems, proteins and enzymes carriers, immunology and purification of nucleic acids [41].…”
Section: Introductionmentioning
confidence: 99%
“…Three main components, namely organic and inorganic reducing agents, capping agents or stabilizers, and metal precursors or silver salts, are used in this method (Figure 2). Hydrogen gas, 94 borohydride, 80,94,95 citrate, 96 ascorbic acid, 97 hydrazine compounds, polyol process, Tollens' reagent, N,N-dimethylformamide, and poly (ethylene glycol) (PEG)-block polymers are the reducing agents most frequently used in this method. These reductants bring about a reduction of silver ions (Ag + ) to metallic silver (Ag 0 ) followed by agglomeration into oligomeric clusters in aqueous and nonaqueous solutions.…”
Section: Introductionmentioning
confidence: 99%